Fibrocystic Disease And Duct Ectasia Of The Breast; Similarities And Differences
Keywords:
Mammary duct ectasia, fibrocystic disease, mastalgia, nipple discharge, nipple retractionAbstract
Introduction: The breast is a dynamic organ that undergoes many physiological changes during the female’s life. Fibrocystic breast disease is characterized by a group of proliferative cell elements while in mammary duct ectasia there is abnormal dilatation of the mammary ducts.
Patients and methods: This retrospective study included 116 female patients divided into two groups, the first group were patients with fibrocystic disease and the second having duct ectasia. Both groups were compared for clinical differences and similarities.
Result: The mean age patients was 33.63 years with a mean BMI of 27.99 with no significant differences between both groups regarding both parameters (P values 0.09 & 0.238). Caffeine, alcohol consumption, smoking, and family history of breast cancer also showed no significant correlation (P values 0.618, 1.00, 0.438, and 1.00). Pain was present in 81% of fibrocystic disease and 75.9% of duct ectasia patients. The pain was non-cyclical in most patients of both groups, cyclical pain was commoner in fibrocystic disease than duct ectasia (34.5% vs. 27.6%). All the correlations with pain were not significant regarding the presence or absence of pain, its location regarding breast quadrants, and whether cyclical or not (P values 0.652, 0.535, and 0.547) respectively.
Breast tenderness was commoner in fibrocystic disease (77.6%) compared to duct ectasia (65.5%) but the correlation was not significant (P value 0.217). Nipple discharge and retraction was present in 44% and 10.6% of patient with duct ectasia respectively and were absent in patient with fibrocystic disease with a very significant between both groups both clinical findings (P values 0.000 and 0.027) respectively.
Breast nodularity was detected in 5.2% of duct ectasia patients and 27.6% of fibrocystic disease patients. Breast lump was more predominant in fibrocystic disease compared to duct ectasia patients (22.4% vs.1.7%) with a very significant difference between both groups (P values 0.002 & 0.001) respectively.
Conclusion: Benign breast disorders are common in females, fibrocystic disease and duct ectasia are among the commonest ones. Breast pain and tenderness are common in both diseases, nipple discharge and retraction are more predominant features of duct ectasia while nodularity and lump are more predominant in fibrocystic disease.
Downloads
Metrics
References
Malherbe, K. and S. Fatima, Fibrocystic Breast Disease. 2019.
Wu, C., et al., A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995–2000. American journal of epidemiology, 2004. 160(10): p. 945-960.
Naveen, N., A. Mukherjee, and V. Mahajan, A clinical study of benign breast disease in rural population. Journal of Evolution of Medical and Dental Sciences, 2013. 2(30): p. 5499-5512.
Rahal, R.M.S., R. De Freitas‐Júnior, and R.R. Paulinelli, Risk factors for duct ectasia. The breast journal, 2005. 11(4): p. 262-265.
Zhang, Y., et al., Clinical characteristics, classification and surgical treatment of periductal mastitis. Journal of thoracic disease, 2018. 10(4): p. 2420.
Beechey-Newman, N., et al., Treatment of mammary duct fistula by fistulectomy and saucerization. World journal of surgery, 2006. 30(1): p. 63-68.
Sweeney, D. and E. Wylie, Mammographic appearances of mammary duct ectasia that mimic carcinoma in a screening programme. Australasian radiology, 1995. 39(1): p. 18-23.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
